Why Pathway Genomics. Advanced Genetic Testing Laboratory. General Health and Wellness. Liquid Biopsy. Hereditary Cancer.

Size: px
Start display at page:

Download "Why Pathway Genomics. Advanced Genetic Testing Laboratory. General Health and Wellness. Liquid Biopsy. Hereditary Cancer."

Transcription

1 Advanced Genetic Testing Laboratory General Health and Wellness Liquid Biopsy Hereditary Cancer Pharmacogenomics Carrier Screening Why Pathway Genomics Founded in 2008, Pathway Genomics offers digital healthcare and genetic testing. Based in San Diego, our CLIA and CAP accredited clinical laboratory provides physicians and their patients in 40+ countries with actionable and accurate precision healthcare information to improve health and wellness. We believe in using the power of genomics first to make proactive, informed decisions about health and lifestyle. Our physician-ordered tests include assays for diet and weight loss, circulating tumor DNA mutations (liquid biopsy), hereditary cancer and carrier screening, as well as metabolic response for many commonly prescribed medications The CAP Certification Mark is a service mark owned by CAP and is used pursuant to a license from CAP. CLIA No. 05D CAP No

2 Advanced Genetic Testing Laboratory Pathway Genomics is a leader in the commercial laboratory industry known for dedication to innovation and cutting-edge technology in the genomic space. Pathway Genomics is a global CAP and CLIA accredited clinical laboratory focused on providing users with the most validated and personalized healthcare information. Our recent partnership with IBM Watson is the first to merge artificial intelligence and deep learning with precision medicine to help both providers and patients. What are the benefits of genetic testing? Genetic testing has potential benefits whether the results are positive or negative for a gene mutation. Test results can provide a sense of relief from uncertainty and help people make informed decisions about managing their healthcare. For example, a negative result can eliminate the need for unnecessary checkups and screening tests in some cases. A positive result can direct a person toward available prevention, monitoring and treatment options. Some test results can uncover hereditary genetic factors (a higher-than-usual chance of having common disorders, such as heart disease, high blood pressure, stroke, certain cancers and diabetes) and help people make decisions about having children. 1

3 How do I incorporate genetic testing into my practice? Utilizing genetic testing as an up-front tool to help inform and guide healthcare decisions for your patients can offer powerful benefits. DNA analysis provides detailed information about your patients regarding how they process nutrients, what exercises and diets work best, hereditary risks for certain cancers and what medications and dosages work best for their body. Here are some simple guidelines to help incorporate genetic testing into your practice: 1. Establish practice protocols for genomics first testing. Baseline your patients with genetic testing before you treat. For example: a. PathwayFit for all patients looking or needing to improve overall health & wellness through positive lifestyle changes (wellness visits) b. Liquid Biopsy testing for the detection of circulating tumor DNA (ctdna) for new and existing patients c. SkinFit to help patients proactively address seven categories of skin health and get personalized skin care treatment choices d. Hereditary Cancer Tests for all high-risk patients (breast, colon, ovarian, etc.) e. Incorporate baseline Pharmacogenomic testing for any patient who is going to be placed on medication for pain, cardiac issues or psychiatric management 2. Register for Atrium our virtual physician toolbox for test ordering & report access 3. Pre-order Test Kits to have on hand for upfront testing 4. Take advantage of included Pathway wellness tools, interpretation guides and staff - Genetic Counselors & Registered Dietitians - to help your patients maximize their health (see page 10 for more or visit 2

4 Pathway Product Groups Empowering patients and physicians with genetics-based information to help make better fitness, nutrition and overall lifestyle choices. Liquid Biopsy Blood-based non-invasive tests for the detection of circulating tumor DNA (ctdna). Hereditary Cancer Understand your family history of cancer and learn about future potential cancer risks. Pharmacogenomics Using genetics to understand and optimize the use of commonly prescribed medications. Carrier Screening Understand potential hereditary risks for future children. PathwayFit SWAB SALIVA PathwayFit analyzes over 80 genetic markers known to impact metabolism, exercise and energy use within the human body. It can be used to make behavioral changes, gain insight into your health and help you and your patients make informed decisions regarding diet, exercise and overall lifestyle. Actionable recommendations such as personalized diet and exercise plans that are based on your patient s genetic profile are included with your results. Pathway also provides access to Registered Dietitians and wellness content to ensure PathwayFit will offer a foundation for change. Healthy Weight DNA Insight SWAB SALIVA Healthy Weight DNA Insight is a comprehensive health and wellness genetic test that provides physicians with a unique combination of information regarding nutrigenetics, medication response and a number of common health conditions. Using a proprietary algorithm, this test also provides physicians with a genetically-matched diet that allows them to make specific recommendations to their patients to help them achieve or maintain a healthy weight. 3

5 Healthy Woman DNA Insight SWAB SALIVA Healthy Woman DNA Insight is a precision health and wellness test that analyzes a variety of genetic markers to provide physicians with valuable information about a woman s dietary and nutritional needs, optimal exercise regiments, potential response to a number of medications and the risk of developing a number of common health conditions. Taking special female health circumstances and challenges such as pregnancy, menopause and other gynecological conditions into consideration, the Healthy Woman DNA Insight report includes a patient-specific weight management plan as well as resources and tips to maximize energy levels. Cardiac Healthy Weight DNA Insight SWAB SALIVA Cardiac Healthy Weight DNA Insight is a unique genetic test that provides physicians with a combination of information regarding nutrigenetics and several common health conditions. Using Pathway s proprietary algorithm, Cardiac Healthy Weight DNA Insight reports deliver genetically-matched diets to physicians allowing them to make specific recommendations to their patients to help them achieve or maintain a healthy weight and improve heart health. Cardiac DNA Insight SWAB SALIVA Cardiac DNA Insight analyzes patients DNA to identify specific genetic variants associated with an increased risk of developing certain heart-related health conditions such as hypertension, atrial fibrillation and myocardial infarction. Cardiac DNA Insight also provides insight into patients potential responses to eight classes of commonly prescribed medications that are used to treat heart-related conditions or are known to affect the cardiovascular system. SkinFit SWAB SALIVA SkinFit is a unique genetic test that analyzes over 70 genetic markers associated with seven categories of skin health. SkinFit reports on the individuals genetic predisposition to sun-induced skin aging and sensitivity, dry skin and wrinkle development, skin inflammation and allergy, skin texture and elasticity, skin s protection against oxidation and glycation, and the skin s nutritional needs. Developed with input from major dermatology and aging science research groups, SkinFit also provides personalized skin care treatment choices to guide patients use of skin care products and nutritional support as needed. 4

6 CancerIntercept Detect Liquid Biopsy CancerIntercept Detect can be used by physicians to test for a set of genomic markers (circulating tumor DNA/ctDNA) that have previously been associated with a number of different cancer types such as breast, ovarian, lung, colorectal, melanoma, head and neck, pancreatic, thyroid, prostate and stomach cancers. CancerIntercept Detect is a non-invasive liquid biopsy that is appropriate for individuals that have not been diagnosed with cancer in the past, but are at an increased risk due to: Known Hereditary Cancer Syndrome o Carrier of a BRCA1 pathogenic variant, etc. Family History of Cancer o Mother & grandmother diagnosed with colon cancer, etc. Lifestyle Choices o History of smoking, etc. Environmental Exposures o Previous exposure to radiation, etc. 60% 60% of ovarian cancer is diagnosed after it has metastasized 61% 61% of of breast cancer is diagnosed when it is still localized (6% metastasized) 20% 20% of colorectal cancer is diagnosed after it has metastasized 57% 57% of lung cancer is diagnosed after it has metastasized CancerIntercept Monitor Liquid Biopsy CancerIntercept Monitor is a blood-based tumor profiling test that provides a non-invasive and less expensive adjunct to traditional biopsy methods. Designed for patients that have been diagnosed with cancer, this genomic profiling test provides valuable information that can be used to both personalize and monitor a patient s oncology care. BreastTrue High Risk Panel Hereditary Cancer SALIVA BreastTrue is Pathway Genomics most comprehensive genetic test for high-risk incidences of breast cancer. BreastTrue analyzes 7 high-risk breast cancer genes including PALB2, BRCA1 and BRCA2. 5

7 BRCATrue Hereditary Cancer SALIVA Pathway Genomics BRCATrue is a next-generation sequencing test that searches for mutations in BRCA1 and BRCA2 genes. According to the National Cancer Institute (NCI), having mutations in either the BRCA1 or the BRCA2 gene significantly increases a patient s risk for breast, ovarian and other types of cancer. BRCATrue is also available in targeted panels where genetic testing can offer additional help within specific segments of the population: BRCATrue Hispanic (8-Site) o Analysis of 8 recurrent pathogenic variants in the Mexican and Hispanic populations BRCATrue Ashkenazi Jewish (3-Site) o Analysis of the 3 common pathogenic variants in the Ashkenazi Jewish population ColoTrue Hereditary Cancer SALIVA ColoTrue is a 14-gene hereditary cancer panel for individuals and families with features suggestive of hereditary colorectal cancer. This panel includes full sequencing and deletion/duplication analysis of 13 genes as well as deletion/duplication analysis of the EPCAM gene. In addition, this test also offers site-specific analysis of the MDM2 SNP309 allele. A pathogenic variant in any of these genes warrants consideration for increased colorectal cancer surveillance. LynchSyndromeTrue Hereditary Cancer SALIVA LynchSyndromeTrue is a comprehensive hereditary cancer panel designed for individuals suspected to be at-risk for Lynch Syndrome. It includes full sequencing of MLH1, MSH2, MSH6, and PMS2 and deletion/duplication analysis for the EPCAM gene. 6

8 Mental Health DNA Insight Pharmacogenomics SWAB SALIVA Mental Health DNA Insight is a clinically-actionable genetic test that analyzes patients DNA to identify specific genetic variants that can affect how they respond to over 50 psychiatric medications indicated for: Major Depressive Disorder (MDD) Schizophrenia Bipolar Disorder Epilepsy Seizures Attention Deficit/Hyperactivity Disorder (ADHD) Anxiety Other Neurological Disorders Mental Health DNA Insight is best suited for individuals who are about to start one of the indicated psychiatric medications, as well as for patients who are currently taking these medications but are not getting the optimal therapeutic response. Pain Medication DNA Insight Pharmacogenomics SWAB SALIVA Pain Medication DNA Insight provides physicians with a personalized roadmap for pain medication management by helping identify the appropriate medications and dosage for their patients. Pain Medication DNA Insight analyzes patients DNA to identify genetic variants that can affect how they respond to the analgesic effects (pain relief) of 13 commonly prescribed pain medications including: Opioids (codeine, methadone, oxycodone, etc.) NSAIDs (ibuprofen, meloxicam, etc.) Other common medications including Methotrexate Toxicity Carrier Status DNA Insight Carrier Screening Carrier DNA Insight is a comprehensive preconception and prenatal carrier screening test that provides physicians with information about the risks of inherited diseases and helps explain the complexities of how genetic mutations can be passed down to their future children. Carrier DNA Insight follows the American College of Obstetricians and Gynecologists (ACOG) recommendations and screens patients for more than 70 recessive genetic diseases. 7

9 All of Pathway. All in one place. Pathway Atrium is our newest tool designed to help clinicians receive all of Pathway, all in one convenient place. Order genetic tests, check report progress and view patient results Pathway Atrium does it all. Instant Notifications: Pathway Atrium makes it easy for clinicians to act on patient reports. They can receive immediate notifications when reports are available or require attention and share reports online with their patients. Easy Ordering: Pathway Atrium lets clinicians place kit and test orders as well as view report status online. This means shorter turnaround times and greater efficiency within practice. Integrated Support: Pathway Atrium has the resources clinicians need - tutorials, live chat with Client Services, technical bulletins and more. Connected Across Devices: Pathway Atrium is designed to work across desktop and tablet allowing clinicians to serve patients anywhere. Login to Pathway Atrium at to submit a lab request or download your patient reports today! 8

10 How can I help my patients take proactive next steps based on their Pathway results? Pathway is committed to helping patients improve health through genetics. That means we don t stop supporting you and your patients once the test results are delivered. We provide ongoing support through our physician interpretation guides, white papers and tech bulletins and we also offer the services below at no charge for you and your patients to take advantage of anytime. Wellness 101 Pathway is dedicated to providing precision genetic testing to improve health and wellness, but unlike many of our competitors we also are committed to ensuring that our providers and patients have the resources, action plans and support to make proactive changes based on their test results. From something as simple as a guide to portion sizes to something as complex as personalized, calorie specific, genetic based diet plans, we have the wellness information you need at your fingertips 24/7. Just visit to get the help you need today. Genetic Counselor services Pathway Genomics has a team of licensed, board-certified genetic counselors available to answer any questions a provider or patient may have regarding our pharmacogenomics, hereditary cancer and/or liquid biopsy tests. Registered Dietitian services Pathway Genomics offers practitioners training and support with our team of licensed Registered Dietitians. We help you to interpret and understand your patients health and wellness reports. 9

11 The Pathway Testing Process After the type of test needed is determined, there are 4 simple steps to get results: SWAB SALIVA 1. Order Kits 2. Collect Order test kits online via Atrium, put in a request with your sales manager or call in an order to Client Services at Based on the type of test needed, you provide a swab, saliva or blood sample. 3. Ship You or your staff mail the kit back to Pathway in the pre-paid shipping envelope. Be sure to include your test requisition and consent form as well. 4. Results Within 2-3 weeks, results will be available to the ordering healthcare professional. 10

12 Pathway Genomics First

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide The benefit of knowing Genetic testing for hereditary cancer A patient support guide Does cancer run in your family? Cancer is more common in some families. Sometimes cancer is caused by a change in a

More information

The Next Generation of Hereditary Cancer Testing

The Next Generation of Hereditary Cancer Testing The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,

More information

Genetic testing for hereditary cancer. An overview for healthcare providers

Genetic testing for hereditary cancer. An overview for healthcare providers Genetic testing for hereditary cancer An overview for healthcare providers Specimen requirements Whole blood Two 4.5 ml EDTA tubes (lavender top) Please wait at least 2 weeks after a packed cell/platelet

More information

Illumina Clinical Services Laboratory

Illumina Clinical Services Laboratory Illumina Clinical Services Laboratory Illumina, Inc. 5200 Illumina Way San Diego, CA 92122, USA Phone: 858.736.8080 Fax: 858.255.5285 everygenome@illumina.com CLIA Certificate No.: 05D1092911 Illumina

More information

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention Know the Basics Risk factors for developing pancreatic cancer

More information

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention Know the Basics Prostate cancer is the most common cancer in

More information

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins. WHAT IS A GENE? CHROMOSOME GENE DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE

More information

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW.

EVOLVE CARRIER GENETIC SCREENS. Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. EVOLVE CARRIER GENETIC SCREENS Better health for generations to come! Be Proactive. SCREEN TODAY. PROTECT TOMORROW. PROTECT THE HEALTH OF YOUR FUTURE CHILDREN BY KNOWING YOUR GENETIC RISKS, TODAY! Carrier

More information

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins. WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE

More information

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer patient guide OvaNext genetic testing for hereditary breast, ovarian, and uterine cancer Because knowing your risk can mean early detection and prevention About half of the women diagnosed with uterine

More information

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES Denise Uyar, MD Associate Professor OB/GYN Chief Gynecologic Oncology Medical College of Wisconsin April 12, 2019 NO DISCLOSURES

More information

A guide to genetic testing for hereditary cancers

A guide to genetic testing for hereditary cancers Cancer Testing Solutions A guide to genetic testing for hereditary cancers The benefit of knowing TM Hereditary cancer genetic testing can play a critical role in managing health Cancer touches millions

More information

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing. Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing. Hereditary cancer and you Approximately 5% to 10% of all cancers develop because a person inherited a genetic

More information

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer Causes of Hereditary Ovarian and Uterine Cancer uterine cancer ovarian cancer Sporadic 75-90% Sporadic 70-80% Hereditary, 5% Lynch syndrome

More information

Counsyl Foresight Carrier Screen. Utmost confidence in every result

Counsyl Foresight Carrier Screen. Utmost confidence in every result Counsyl Foresight Carrier Screen Utmost confidence in every result EXTENDING THE BENEFITS OF CARRIER SCREENING Elevate quality of care with expanded carrier screening (ECS) Carrier screening is used to

More information

Information for You and Your Family

Information for You and Your Family Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the

More information

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Talking Genomes with Your Patients Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Objectives Review the importance of physician familiarity with genomic testing

More information

PAIN MEDICATION DNA INSIGHT

PAIN MEDICATION DNA INSIGHT Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya, M.D. PAIN MEDICATION DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Caucasian ORDERING HEALTHCARE PROESSIONAL Nilesh

More information

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Assessment and Management of Genetic Predisposition to Breast Cancer Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Overview The role of the Cancer Genetics team NICE guidelines for Familial Breast

More information

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor Cancer Survivorship Symposium Cancer and Heredity January 16, 2017 Jeanne P. Homer, MS Licensed Certified Genetic Counselor Outline Cancer and Heredity Hereditary Cancer Risk Assessment & Genetic testing

More information

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention Know the Basics Cancer occurs in about 1 in 3 adults in their lifetime types

More information

Sequencing. Deletion/Duplication Analysis. How Does Genetic Testing for Cancer Work?

Sequencing. Deletion/Duplication Analysis. How Does Genetic Testing for Cancer Work? There are several steps involved with genetic testing for cancer predisposition. The first step would be to meet with a specialist, such a genetic counselor, who can assess your medical and family history

More information

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention

patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention patient guide Hereditary Cancer genetic testing panels Because knowing your risk can mean early detection and prevention Some of the most common cancers diagnosed are: Know the Basics breast prostate uterine

More information

Hereditary Gynecologic Cancer

Hereditary Gynecologic Cancer patient guide Hereditary Gynecologic Cancer genetic testing panels Because knowing your risk can mean early detection and prevention About half of the women diagnosed with uterine (endometrial) cancer

More information

Genetic screening. Martin Delatycki

Genetic screening. Martin Delatycki 7 Genetic screening Martin Delatycki Case study 1 Vanessa and John are planning a family. They see their general practitioner and ask whether they should have any tests prior to falling pregnant to maximise

More information

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania Aging Family history Early menarche Late menopause Nulliparity Estrogen / Progesterone use after menopause More than two alcoholic

More information

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer

Lynch Syndrome. patient guide. genetic testing for hereditary colorectal and uterine cancer patient guide Lynch Syndrome genetic testing for hereditary colorectal and uterine cancer Because knowing your risk can mean early detection and prevention Know the Basics People with Lynch syndrome may

More information

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention

patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention patient guide RenalNext genetic testing for hereditary kidney cancer Because knowing your risk can mean early detection and prevention Know the Basics Risk factors for developing kidney cancer include

More information

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent.

So how much of breast and ovarian cancer is hereditary? A). 5 to 10 percent. B). 20 to 30 percent. C). 50 percent. Or D). 65 to 70 percent. Welcome. My name is Amanda Brandt. I am one of the Cancer Genetic Counselors at the University of Texas MD Anderson Cancer Center. Today, we are going to be discussing how to identify patients at high

More information

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome Lynch Syndrome A Patient s Guide to Genetic Testing for Lynch Syndrome What is Lynch Syndrome? Lynch syndrome is an inherited condition that increases your risk of developing colon cancer and other cancers

More information

Cancer Institute. cancer institute Program overview Report 2013

Cancer Institute. cancer institute Program overview Report 2013 Cancer Institute cancer institute Program overview Report 2013 Saint Francis Medical Center in Cape Girardeau, Mo., is a regional leader in the battle against cancer, bringing new techniques, ideas and

More information

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer GYNplus genetic testing for hereditary ovarian and/or uterine cancer What Are the Causes of Hereditary Ovarian and Uterine Cancer? uterine cancer ovarian cancer sporadic 70-80% hereditary 5% Lynch syndrome

More information

Medical Policy Update

Medical Policy Update Medical Policy Update Summer 2017 Highlights of recent medical policy revisions as well as any new medical policies approved by Prevea360 Health Plan s Medical Policy Committee are shown below. The Medical

More information

Welcome! Here s our agenda for today:

Welcome! Here s our agenda for today: Welcome! Here s our agenda for today: What is ovarian cancer? What causes it? When does genetic testing come in? When are families at risk for ovarian cancer? What are the treatments? 3 things to remember

More information

Does Cancer Run in Your Family?

Does Cancer Run in Your Family? Does Cancer Run in Your Family? A Patient s Guide to Hereditary Breast and Ovarian Cancer Syndrome What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that

More information

Precision Medicine and Genetic Counseling : Is Yes always the correct answer?

Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Beverly M. Yashar, MS, PhD, CGC Director, Graduate Program in Genetic Counseling Professor, Department of Human Genetics. (yashar@umich.edu)

More information

Ovarian Cancer Causes, Risk Factors, and Prevention

Ovarian Cancer Causes, Risk Factors, and Prevention Ovarian Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for ovarian cancer.

More information

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention Know the Basics Breast cancer is the most common cancer in women

More information

GENETIC TESTING FOR HEREDITARY CANCER

GENETIC TESTING FOR HEREDITARY CANCER UnitedHealthcare Oxford Clinical Policy GENETIC TESTING FOR HEREDITARY CANCER Policy Number: DIAGNOSTIC 004.27 T2 Effective Date: November 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS

More information

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention Know the Basics The average age of diagnosis for melanoma is 63 YEARS

More information

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY BRCA 1/2 Breast cancer testing THINK ABOUT TOMORROW, TODAY 5 10% of patients with breast and/or ovarian cancer have a hereditary form1. For any individual carrying a mutation in BRCA1 or BRCA2, the lifetime

More information

Learn your genetic risk for the most common hereditary cancers.

Learn your genetic risk for the most common hereditary cancers. Learn your genetic risk for the most common hereditary cancers. color.com Color analyzes 30 genes including BRCA1 and BRCA2 to help women and men understand their risk for the most common hereditary cancers,

More information

GENETIC TESTING WHAT I SHOULD KNOW. COMPREHENSIVEDx CLEAR. BRCADx/BREASTDx CLEAR. COLODx CLEAR. LYNCHDx CLEAR SPECIALTY MEDICAL LAB

GENETIC TESTING WHAT I SHOULD KNOW. COMPREHENSIVEDx CLEAR. BRCADx/BREASTDx CLEAR. COLODx CLEAR. LYNCHDx CLEAR SPECIALTY MEDICAL LAB GENETIC TESTING WAT I SOULD KNOW COMPREENSIVEDx CLEAR BRDx/BREASTDx CLEAR COLODx CLEAR LYNCDx CLEAR SPECIALTY MEDIL LAB BENEFITS OF GENETIC TESTING Genetic testing provides physicians with the ability

More information

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian ANNOUNCER OPEN: Welcome to CME on ReachMD. This segment, entitled Inherited Susceptibility to Cancer: What Do Primary Care Providers

More information

Genetic Testing: who, what, why?

Genetic Testing: who, what, why? Genetic Testing: who, what, why? Gina Westhoff MD LMG Gynecologic Oncology March 16, 2019 Disclosures Speaker for Merck (unrelated to today s topic) Objectives Determine who should undergo genetic risk

More information

DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS?

DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS? DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS? IF SO, ASK YOUR DOCTOR IF THE PREVENTEST CAN HELP PREDICT YOUR

More information

Introduction to Evaluating Hereditary Risk. Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center

Introduction to Evaluating Hereditary Risk. Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center Introduction to Evaluating Hereditary Risk Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center Objectives Describe genetic counseling and risk assessment Understand

More information

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer

More information

Result Navigator Positive Test Result: MSH6

Result Navigator Positive Test Result: MSH6 Result Navigator Positive Test Result: MSH6 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc)

BRCA1 and BRCA2. patient guide. genetic testing for hereditary breast and ovarian cancer (hboc) patient guide BRCA1 and BRCA2 genetic testing for hereditary breast and ovarian cancer (hboc) Because knowing your risk can mean early detection and prevention Know the Basics People with HBOC may have

More information

Why Test for Hereditary Cancer in Preventive Care?

Why Test for Hereditary Cancer in Preventive Care? Why Test for Hereditary Cancer in Preventive Care? Millions of people are sidelined by cancer. Wouldn't it be worth it for your patients to know their risk? background HEREDITARY (5-10%) More than 1 in

More information

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You? A Patient s Guide to Hereditary Cancer Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer. This is

More information

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention Know the Basics Cancer occurs in about 1 in 3 adults in their lifetime

More information

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing

More information

Cancer Conversations

Cancer Conversations Cancer Conversations Announcer: Welcome to Cancer Conversations, a podcast series from Dana-Farber Cancer Institute. In this Episode from July 2014, Dr. Huma Rana, Clinical Director of Dana-Farber s Center

More information

Clinical Genetics Service

Clinical Genetics Service Clinical Genetics Service Helping You and Your Family Reduce Your Risk Your appointment is at AM/PM North Office Location 7714 Conner Road Suite 107 Knoxville, TN 37849 West Office Location Tennova Turkey

More information

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center Definitions: DNA: The material found in our cells - the instructions

More information

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG Hereditary Breast and Ovarian Cancer 2015 Rebecca Sutphen, MD, FACMG Among a consecutive series of 11,159 women requesting BRCA testing over one year, 3874 responded to a mailed survey. Most respondents

More information

Myriad Genetics Corporate Presentation 6/4/13

Myriad Genetics Corporate Presentation 6/4/13 Myriad Genetics Corporate Presentation 6/4/13 Forward Looking Statement Some of the information presented here today may contain projections or other forward-looking statements regarding future events

More information

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals. The gene is a tumor suppressor gene. Tumor suppressor genes slow down cell division, repair DNA mistakes, or tell cells when to die. When they don't work properly, cells can grow out of control, which

More information

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation

More information

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information GeneticsNow TM A Guide to Testing Hereditary Conditions in Women & Men Patient & Physician Information How can BRCA status affect your health? Everyone has BRCA1 and BRCA2 genes. However, sometimes the

More information

Leading-edge cancer treatment + compassionate care

Leading-edge cancer treatment + compassionate care CARE + COVERAGE ˡ NORTHERN CALIFORNIA Leading-edge cancer treatment + compassionate care Working together to bring you hope and healing When you hear the word cancer, it can be a frightening, confusing

More information

EVOLVE FERTILITYREADY TM SCREENS

EVOLVE FERTILITYREADY TM SCREENS FOR MEN & WOMEN EVOLVE FERTILITYREADY TM SCREENS Assess genetic factors that cause infertility and know more about your reproductive health. Be Proactive. SCREEN TODAY. PROTECT TOMORROW. #1 in Genetic

More information

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations

TumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing

More information

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center

Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening. Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Breast Cancer Risk Assessment: Genetics, Risk Models, and Screening Amie Hass, MSN, ARNP, FNP-BC Hall-Perrine Cancer Center Disclosure- I DO NOT HAVE any relevant financial interest with any entity producing,

More information

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed

More information

2018 Edition The Current Landscape of Genetic Testing

2018 Edition The Current Landscape of Genetic Testing 2018 Edition The Current Landscape of Genetic Testing Market growth, reimbursement trends, challenges and opportunities November April 20182017 EXECUTIVE SUMMARY Concert Genetics is a software and managed

More information

Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina

Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to finally be able to put these genomics related data items

More information

Clinical Quality Assurance Measures at Myriad Genetic Laboratories:

Clinical Quality Assurance Measures at Myriad Genetic Laboratories: Clinical Quality Assurance Measures at Myriad Genetic Laboratories: Increasing the Clinical Utility and Cost-Effectiveness of Genetic Testing for Hereditary Cancer Syndromes for Patients, Healthcare Providers

More information

Result Navigator. Positive Test Result: CDH1. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: CDH1. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: CDH1 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

WELCOME. Taking Care of Your Health. April 30, 8 am to noon WELCOME Taking Care of Your Health April 30, 8 am to noon Cancer: Know Your Risk Emily Kuchinsky, MS, CGC, Certified Genetic Counselor Sporadic Cancer Lifetime Probability- Women Family Cluster Risk factors

More information

Passport to Health Preventing and Recognizing Gynecologic Cancers

Passport to Health Preventing and Recognizing Gynecologic Cancers Passport to Health Preventing and Recognizing Gynecologic Cancers Presented by: Obstetrician/Gynecologist Leigh Bauer, M.D. They can sneak up on you. 2 Gynecologic cancers, that is. Knowing the facts can

More information

Lynch Syndrome. Angie Strang, PGY2

Lynch Syndrome. Angie Strang, PGY2 Lynch Syndrome Angie Strang, PGY2 Background Previously hereditary nonpolyposis colorectal cancer Autosomal dominant inherited cancer susceptibility syndrome Caused by defects in the mismatch repair system

More information

Proactive Patient Paves the Way for Genetic Testing of Eight Family Members

Proactive Patient Paves the Way for Genetic Testing of Eight Family Members CASE STUDY Proactive Patient Paves the Way for Genetic Testing of Eight Family Members Quick Summary Samar Mohite * was diagnosed with colon adenocarcinoma at the age of 49 years. Genetic counselling was

More information

College of American Pathologists

College of American Pathologists College of American Pathologists Comments to the Food and Drug Administration on the draft guidance In Vitro Companion Diagnostics Devices October 12, 2011 College of American Pathologists 1350 I Street,

More information

Tell a Friend, Save a Life:

Tell a Friend, Save a Life: Tell a Friend, Save a Life: The Breast Cancer Prevention & Detection Kit This Kit is brought to you as a public service by the National Foundation for Cancer Research. About the Tell a Friend, Save a Life

More information

NUTRIFIT LINE. Adapt your life to your body s needs

NUTRIFIT LINE. Adapt your life to your body s needs NUTRIFIT LINE Adapt your life to your body s needs Is it possible to adapt your lifestyle to your body s requirements? With our nutritional plan and healthy lifestyle advice based on your specific genetic

More information

FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM

FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM THE ESSENTIAL PANEL There are many unknowns in life. FAMILY PLANNING DOESN T HAVE TO BE ONE OF THEM PLANNING FOR A FAMILY IS A BIG DECISION TAKE STEPS TOWARD A HEALTHY FUTURE WITH NXGEN GENETIC CARRIER

More information

It would be hard to identify the medical

It would be hard to identify the medical You no longer have to be sick to get tested for serious diseases like cancer or diabetes. In fact, if you or your family discovers you re likely to get these conditions, there may be preventative measures

More information

Primary Care Approach to Genetic Cancer Syndromes

Primary Care Approach to Genetic Cancer Syndromes Primary Care Approach to Genetic Cancer Syndromes Jason M. Goldman, MD, FACP FAU School of Medicine Syndromes Hereditary Breast and Ovarian Cancer (HBOC) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)

More information

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice

The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice The impact of hereditary breast and ovarian cancer (HBOC) syndrome testing on patient management and your practice Use BRACAnalysis as a guide in your medical and surgical management BRACAnalysis testing

More information

Addressing Information Gaps in Advanced Prenatal Screening: What Your Expecting Patients Need to Know

Addressing Information Gaps in Advanced Prenatal Screening: What Your Expecting Patients Need to Know Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/addressing-information-gaps-advancedprenatal-screening-what-your-expecting-patients-need-know/7651/

More information

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes. Hello. My name is Maureen Mork and I m a Certified Genetic Counselor in the Clinical Cancer Genetics Program at The University of Texas MD Anderson Cancer Center. I ll be lecturing today on the Cancer

More information

Genetic testing for hereditary cancer

Genetic testing for hereditary cancer Genetic testing for hereditary cancer THE GENETICS OF HEREDITARY CANCER About half of all men and one-third of all women in the US will develop cancer during their lifetimes. Approximately 5% to 10% of

More information

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer A Patient s Guide to risk assessment Hereditary Colorectal Cancer Hereditary Cancer Testing: Is it Right for You? Overview of Syndromes This workbook is designed to help you decide if hereditary cancer

More information

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast and Ovarian Cancer is a genetic condition which

More information

ProstateGene What is hereditary prostate cancer? What are genes?

ProstateGene What is hereditary prostate cancer? What are genes? ProstateGene ProstateGene What is hereditary prostate cancer? Prostate cancer is the most common cancer among men in the UK. Unfortunately, 1 in 8 men will be diagnosed with prostate cancer, with 75% being

More information

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017 Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Moderate Penetrance Variants Associated with Breast Cancer in File Name: Origination: Last CAP Review: Next CAP Review: Last Review: moderate_penetrance_variants_associated_with_breast_cancer_

More information

Genetic Determinants, Risk Assessment and Management

Genetic Determinants, Risk Assessment and Management Genetic Determinants, Risk Assessment and Management Rachel Rando, MS, CGC Genetic Counselor Hunterdon Regional Cancer Center Flemington, NJ I have no disclosures. Acknowledgements: Staff of Hunterdon

More information

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention

patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention patient guide BrainTumorNext genetic testing for hereditary brain tumors Because knowing your risk can mean early detection and prevention Know the Basics Brain tumors are the most common tumor/cancer

More information

The Genetics of Breast and Ovarian Cancer Prof. Piri L. Welcsh

The Genetics of Breast and Ovarian Cancer Prof. Piri L. Welcsh The Genetics of Breast Piri L. Welcsh, PhD Research Assistant Professor University of Washington School of Medicine Division of Medical Genetics 1 Genetics of cancer All cancers arise from genetic and

More information

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION CentoCancer our most comprehensive oncogenetics panel for hereditary mutations Hereditary pathogenic variants confer an increased risk of developing

More information

Providence Medical Group

Providence Medical Group Providence Medical Group To our valued patients: In order to provide you with our full attention when you come for an appointment, we would like to ask you to be aware of the following guidelines. Insurance

More information